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Abstract
The transcription of individual genes is determined by combinatorial interactions between DNA–binding transcription
factors. The current challenge is to understand how such combinatorial interactions regulate broad genetic programs that
underlie cellular functions and disease. The transcription factors Hnf1a and Hnf4a control pancreatic islet b-cell function and
growth, and mutations in their genes cause closely related forms of diabetes. We have now exploited genetic epistasis to
examine how Hnf1a and Hnf4a functionally interact in pancreatic islets. Expression profiling in islets from either Hnf1a
+/2 or
pancreas-specific Hnf4a mutant mice showed that the two transcription factors regulate a strikingly similar set of genes. We
integrated expression and genomic binding studies and show that the shared transcriptional phenotype of these two
mutant models is linked to common direct targets, rather than to known effects of Hnf1a on Hnf4a gene transcription.
Epistasis analysis with transcriptomes of single- and double-mutant islets revealed that Hnf1a and Hnf4a regulate common
targets synergistically. Hnf1a binding in Hnf4a-deficient islets was decreased in selected targets, but remained unaltered in
others, thus suggesting that the mechanisms for synergistic regulation are gene-specific. These findings provide an in vivo
strategy to study combinatorial gene regulation and reveal how Hnf1a and Hnf4a control a common islet-cell regulatory
program that is defective in human monogenic diabetes.
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Introduction
In all eukaryotic organisms a limited number of DNA binding
transcriptional regulators determine a much greater number of
genetic programs. This is made possible by a code whereby unique
combinations of regulators define cellular fates or functions. The
combinatorial nature of transcriptional regulation has been
demonstrated in countless studies that have dissected individual
gene regulatory regions [1–4]. A major underlying principle is that
DNA-binding transcriptional activators often function synergisti-
cally due to cooperativity in binding or recruitment of regulatory
complexes [1,3]. Other common functional interactions include
redundancy or antagonism between different factors binding to the
same regulatory region [1–4].
A true understanding of transcriptional programs will require
the dissection of transcription factor interactions in global cellular
contexts, rather than in single genes. In recent years, the function
of several mammalian transcription factors has been examined by
profiling gene expression in genetically perturbed cells [5]. Such
studies provide a broad inventory of genes that are dependent on
selected transcription factors, but they do not in themselves reveal
how different factors interact functionally. Other studies have
determined the genomic binding sites of single or multiple
transcription factors [6,7]. However, knowing that a regulator
binds to a gene does not clarify if the binding event leads to
positive, negative, or no regulation. Numerous studies, in fact,
suggest that a major fraction of transcription factor binding events
might be functionally dispensable [8–13]. Similarly, when more
than one factor binds to the same gene, several functional
interactions are possible. New approaches are therefore necessary
to understand how transcriptional regulators engage in the
combinatorial interactions that regulate cellular programs.
The genetics of human diabetes provides a paradigm to study
transcriptional programs in pancreatic b-cells [14–17]. Heterozy-
gous mutations in several genes encoding DNA binding transcrip-
tion factors cause autosomal dominant diabetes, or Maturity Onset
Diabetes of the Young (MODY) [14–16,18]. Mutations in HNF1A
and HNF4A (encoding for hepatocyte nuclear factor 1a and 4a)
are responsible for the most common form of monogenic diabetes
[14,15]. Despite transient differences in newborns, the diabetic
phenotype in HNF1A and HNF4A patients shares many features,
including similar disease progression curves, insulin secretory
responses, and sensitivity to hypoglycemic drugs [18]. Human
genetics therefore suggests that HNF1A and HNF4A may be
involved in a common regulatory network in b-cells.
One simple explanation for the shared HNF1A and HNF4A-
deficient phenotype is that Hnf1a regulates the transcription of the
Hnf4a pancreas-specific promoter[19–21]. However, several lines of
evidence point to additional regulatory interactions. For example, a
large-scale binding study found that many Hnf1a-bound genes are
PLoS Genetics | www.plosgenetics.org 1 May 2010 | Volume 6 | Issue 5 | e1000970also bound by Hnf4a [6]. Other studies have shown that Hnf1a
physically interacts in vitro and in vivo with the Hnf4a AF2 domain
[22–24]. Such interactions have been linked to observations that
overexpression of Hnf1a inhibits Hnf4a-regulation of targets, and
overexpression of Hnf4a inhibits Hnf1a function [23–25]. Other
studies showed that Hnf4a can increase Hnf1a function in synthetic
promoters that only contain an Hnf1a binding site [22], or in
promoters containing binding sites for both factors [2,26,27].
Becausesofarmostfunctionalstudieshaveemployedoverexpression
systems incultured non-b cell lines,the true functional consequences
of Hnf1a/Hnf4a interactions in islet-cells remain unclear.
We have now developed a strategy to study the integrated
function of Hnf1a and Hnf4a in pancreatic islet cells. We profiled
gene expression in genetic models with weak phenotypes and show
that Hnf1a and Hnf4a regulate a remarkably similar set of genes.
Using binding studies and epistasis analysis of transcriptome
phenotypes, we demonstrate that the common function of Hnf1a
and Hnf4a in pancreatic islet cells is in part due to global synergistic
interactions between the two factors at common direct targets. The
results provide an approach to decipher transcriptional networks in
mammalian cells, and reveal novel insight into a common
regulatory program that underlies human monogenic diabetes.
Results
Hnf4a-deficient pancreatic islets exhibit an impaired
transcriptional program
The goal of this study was to understand the integrated
transcriptional function of Hnf1a and Hnf4a in pancreatic islets.
To study Hnf4a function, we generated pancreas-specific Hnf4a
knock-out mice (Hnf4a
pKO), and confirmed that this targeted
deletion caused a marked reduction of Hnf4a gene mRNA in islet-
cells (Figure 1A).
In keeping with previous studies of mice with b-cell specific
ablation of Hnf4a (Hnf4a
betaKO) [28–30], Hnf4a
pKO mice developed
a mild complex phenotype, with very subtle glucose intolerance
and a slightly reduced fasting glycemia (Figure S1).
Despite this mild metabolic phenotype, Hnf4a
pKO mice showed a
clear islet transcriptional phenotype (Table S1). Downregulated
genes encoded for varied cellular roles, including the metabolism
of steroids, glucose, and amino acids (Table S1 and Table S2).
Others encoded for regulators of signal transduction and cell
growth, consistent with a previous report in Hnf4a
betaKO islets [31],
or were in keeping with the proposed role of Hnf4a in epithelial
differentiation [32] (Table S1 and Table S2). Upregulated genes
included genes known to form part of the epithelial mesenchymal
transition process (Table S2). Overall, the functional classes that
were perturbed in Hnf4a-deficient islets were remarkably similar to
those reported in Hnf1a
-/- islets[11].
Hnf1a haploinsufficient mice reveal Hnf1a-dependent
transcription in islets
To study Hnf1a transcriptional function, we used Hnf1a
+/2
mice. As opposed to mice with homozygous Hnf1a mutations,
which develop diabetes, this model has no documented in vitro or in
vivo metabolic disturbances (Figure S2)[33–36]. Also in keeping
with previous studies, Hnf1a
+/2 islets exhibit only marginal
downregulation of Hnf4a (,70–90% of normal values)
(Figure 1B)[36]. Hnf1a
+/2 mice thus lack two elements that are
thought to exert an indirect impact on islet gene expression in
homozygous Hnf1a mutant islets. Array analysis revealed a
transcriptional phenotype in Hnf1a
+/2 islets, with 196 non-
redundant genes downregulated .1.5-fold in Hnf1a
+/2 islets at a
nominal P value,0.01. We validated this dataset with gene-
specific assays in 20 genes from independent Hnf1a
+/2 mice
(Figure S4A). Furthermore, genes that were bound by Hnf1a and
downregulated in homozygous Hnf1a mutant islets were signifi-
cantly downregulated in Hnf1a
+/2 islets (Figure S4B). Thus,
expression profiling in Hnf1a
+/2 islets provides a tool to assess the
transcriptional function of Hnf1a in this tissue.
Hnf4a- and Hnf1a-deficient islets share a common
transcriptional signature
We next compared expression changes in Hnf1a
+/2 and
Hnf4a
pKO islets. This revealed a striking correlation between the
two models (r=0.57, P=10
26) (Figure 2A–2C). Gene set
enrichment analysis (GSEA) showed that genes that were
significantly downregulated in Hnf4a
pKO islets were downregulated
in Hnf1a
+/2 islets (Figure 2D, P,0.001). Conversely, genes
downregulated in Hnf1a
+/2 islets were downregulated in Hnf4a
pKO
islets (Figure 2E, P,0.001). Not surprisingly, gene expression
changes were consistently lower in the Hnf1a haploinsufficient
Figure 1. Hnf1a and Hnf4a expression in mutant models. (A,B)
Expression of Hnf1a and Hnf4a mRNA in islets from (A) Hnf4a
pKO and (B)
Hnf1a
+/2 male mice. Results were normalized to Hprt mRNA and are
expressed relative to littermate wild-type controls. * P,0.05.
doi:10.1371/journal.pgen.1000970.g001
Author Summary
The transcriptional activity of each gene is typically
determined by multiple transcription factors. This concept
has been well established in studies of single genes.
However, transcription factors do not simply regulate
single genes, they also control broad gene programs that
underlie cellular function and disease. Understanding how
combinations of transcription factors interact at the level
of cellular regulatory programs remains a challenge.
Humans with mutations in the genes encoding for the
transcription factors Hnf1a and Hnf4a develop similar
forms of diabetes that result from abnormal insulin
secretion, suggesting that the two factors might have
related functions in insulin-producing islet-cells. We now
show that Hnf1a or Hnf4a bind to a common set of genes
and that islet-cells from mice in which either Hnf1a or
Hnf4a has been selectively disrupted show abnormal
expression of similar genes. By comparing the gene
expression defects of mice with mutations in either Hnf1a,
Hnf4a, or both genes, we determined that Hnf1a and
Hnf4a regulate common target genes through synergistic
mechanisms. These results thus provide insight into a
regulatory network that fails in human diabetes. Similar
genetic strategies can also be employed to unravel how
other transcription factors interact functionally in native
cellular contexts.
Epistasis of Monogenic Diabetes Regulators
PLoS Genetics | www.plosgenetics.org 2 May 2010 | Volume 6 | Issue 5 | e1000970Figure 2. Hnf1a and Hnf4a regulate a common set of genes. (A) Correlation of mutant/wild-type Log2 gene expression ratios in Hnf4a
pKO
versus Hnf1a
+/2 islets. (B) Validation of 22 genes using gene-specific qPCR. (C) Heatmap of expression ratios in Hnf4a
pKO and Hnf1a
+/2 islets for the 50
most downregulated genes in Hnf4a
pKO islets. (D) Expression of Hnf1a-dependent genes in Hnf4a
pKO islets. Grey dots represent average expression
values of genes in Hnf4a
pKO versus control islets. We superimposed red dots to show the subset of genes downregulated in Hnf1a
+/2 islets. (E)
Expression of Hnf4a-dependent genes in Hnf1a
+/2 islets. Grey dots are expression values of all genes, superimposed blue dots are the subset of genes
downregulated in Hnf4a
pKO islets.
doi:10.1371/journal.pgen.1000970.g002
Epistasis of Monogenic Diabetes Regulators
PLoS Genetics | www.plosgenetics.org 3 May 2010 | Volume 6 | Issue 5 | e1000970islets compared with islets with biallelic inactivation of Hnf4a
(Figure 2A–2E). We confirmed the correlation with gene-specific
assays (Figure 2B), and with an independent comparison of
Hnf1a
+/2 versus Hnf4a
pKO mice of 16 rather than 8 weeks of age
(not shown, and Table S1).
These common gene expression changes were unexpected,
because Hnf1a expression in Hnf4a
pKO islets was unperturbed
(Figure 1A) (as previously shown for Hnf4a
betaKO mice[28–30]) and
Hnf4a expression was only marginally reduced in Hnf1a
+/2 islets
(Figure 1B, and [36]). In conclusion, the analysis of models that
minimize the impact of indirect perturbations showed that Hnf1a
and Hnf4a regulate a common set of genes in pancreatic islets.
Hnf1a targets are similarly impaired in Hnf4a- and Hnf1a-
deficient islets
Previous studies provide two possible mechanisms whereby
Hnf1a
+/2 versus Hnf4a
pKO islets could exhibit a similar transcrip-
tional phenotype (Figure 3A). One is that Hnf1a and Hnf4a
frequently bind the same genes in human liver and islets [6]. We
confirmed this finding using mouse liver binding datasets reported
elsewhere [8,11] (Figure 3B), after estimating that ,75% of
Hnf4a-bound genes in islets may also bound in liver (Figure. S8).
However, co-occupancy does not per se explain the similar gene
expression changes in the two mutant models, because for most
genes bound by Hnf1a or Hnf4a, gene expression is not altered in
the respective knock-out tissues [8,11]. An alternate explanation
for the similar transcriptional phenotypes is that Hnf1a regulates
Hnf4a gene transcription in islets (Figure 3A) [11,19–21]. In the
current study we used heterozygous Hnf1a mutant islets because
Hnf4a was not significantly altered (unlike homozygous Hnf1a
mutants). However, it remained possible that a subtle decrease in
Hnf4a expression in Hnf1a
+/2 islets caused the common transcrip-
tional phenotype (which would thus result from a perturbation of
Hnf4a in both models). We predicted that if this were true we
Figure 3. Expression of Hnf1a targets is impaired in Hnf4a-deficient islets. (A) Alternate models of Hnf1a and Hnf4a network structures that
could potentially underlie the similar transcriptomes in Hnf4a
pKO and Hnf1a
+/2 islets, and expected functional perturbation of Hnf1a bound genes in
each case. (B) The analysis of previously reported [8,11] mouse liver binding datasets showed that Hnf1a and Hnf4a preferentially bind the same
genes, as reported in human islets and liver[6]. Hypergeometric distributions were tested to calculate significance values. (C) Hnf1a, Hnf4a and
Hnf1a/Hnf4a binding were enriched in genes that were significantly downregulated 2-fold in Hnf4a
pKO and Hnf1a
-/- islets. Hypergeometric
distributions were tested to calculate significance values. (D) Most significant over-represented evolutionary conserved sequence element in 10 Kb
surrounding transcription start sites of genes that were downregulated in Hnf4a
pKO islets. The canonical HNF1 matrix is shown below. Motifs
matching Hnf4a, or Hnf1a and Hnf4a binding sequences were also overrepresented in genes downregulated in Hnf4a
pKO and Hnf1a
-/- islets,
respectively (not shown).
doi:10.1371/journal.pgen.1000970.g003
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the two models, whereas the direct targets of the upstream factor
of this hierarchy, Hnf1a, should be impaired only in Hnf1a-
deficient islets (Figure 3A).
We thus tested if transcription of Hnf1a-bound genes was
impaired in mice deficient for either factor. Hnf1a binding
frequency was increased 5-fold among genes that were downreg-
ulated in homozygous Hnf1a mutant islets (Figure 3C). Remark-
ably, Hnf1a binding frequency was also increased 5-fold in
promoters of genes that were downregulated in Hnf4a-deficient
islets (Figure 3C). We also found that Hnf1a bound genes that
were downregulated in Hnf1a
-/- islets were downregulated in
Hnf4a-deficient islets (Figure S5). In silico studies confirmed these
findings, as the most overrepresented conserved motif in genes
downregulated in Hnf4a
pKO islets was identical to the canonical
HNF1 binding sequence (Figure 3D). Thus, Hnf1a targets are
impaired in Hnf4a deficient islets to a similar extent as in Hnf1a
deficient islets.
Genes that were downregulated in both Hnf4a- and Hnf1a-
deficient islets also showed significantly enriched Hnf4a binding
and a 4 to 6-fold higher co-occupancy rate than non-regulated
genes (Figure 3C). Collectively, these results argue that the shared
transcriptome in our models is not due to the known Hnf1a-Hnf4a
transcriptional hierarchy, and instead support that it is linked to
the regulation of common target genes.
Hnf1a and Hnf4a function is interdependent in
pancreatic islets
The above findings were consistent with an interdependent
function of Hnf1a and Hnf4a, or alternatively with the regulation
of common genes in a mechanistically independent manner. To
discriminate among these possibilities, we compared expression
profiles in single mutant (Hnf1a
+/2 and Hnf4a
pKO) versus double
mutant (Hnf1a
+/2 Hnf4a
pKO) islets (Figure 4A). We predicted that if
Hnf1a and Hnf4a act independently in any gene that is
downregulated in both single mutant islets, the expression ratio
in double mutant (Hnf1a
+/2 Hnf4a
pKO) islets should reflect the
product of the two single mutant expression ratios. By contrast, if
the two factors regulate a gene in an interdependent manner, the
expression in double mutant islets should differ from this
expectation (Figure 4A).
For each gene that was downregulated in both Hnf1a
+/2 and
Hnf4a
pKO single mutant islets we calculated an epistasis e value that
measures the deviation from expectation. An e value . 0 indicates
that the expression ratio in Hnf1a
+/2 Hnf4a
pKO islets is higher (less
perturbed) than expected from the independent effects of the two
single mutant values. As shown in Figure 4C, the distribution of e
values was unambiguously greater than 0. Figure 4D further
illustrates this concept, showing that the perturbation of individual
genes in Hnf1a
+/2 Hnf4a
pKO islets was epistatic (P=10
235). Similar
findings were confirmed in independent mice using qPCR
(quantitative PCR) rather than oligonucleotide chips (Figure S6).
The high co-occupancy rate of Hnf1a and Hnf4a also raises the
question whether these two factors might exert redundant
functions at some targets. Because selecting genes that are
downregulated in the single mutant islets can represent a bias
against redundancy, we also performed this analysis in all genes
that were downregulated .3 fold in double Hnf1a
+/2 Hnf4a
pKO
mutant islets. Most such genes were markedly downregulated in
the single mutants, and again had e values exceeding 0 (Figure S7),
thus showing that although Hnf1a and Hnf4a often bind to the
same genes, their function is not redundant in islets. In keeping
with these findings, the mild glucose intolerance phenotype
observed in Hnf4a
pKO mice was not further impaired in Hnf1a
+/2
Hnf4a
pKO mice (Figure S3). In summary, these results indicate that
Hnf1a and Hnf4a bind to similar targets and act through
interdependent regulatory mechanisms in islets, thus leading to a
common transcriptional phenotype in Hnf1a
+/2 and Hnf4a
pKO
islets.
Gene-specific mechanisms for interdependent activation
To assess the mechanisms underlying the interdependent
function of Hnf1a and Hnf4a in common target genes, we
examined whether their binding is interdependent. Because Hnf1a
expression is unaltered in Hnf4a-deficient mouse islets, we were
able to use this model to study whether Hnf4a is required for
Hnf1a binding to common targets. We selected eight genes that
we have previously shown are bound by Hnf1a and are
functionally dependent on Hnf1a in islets [11](Figure 5A). All of
them were also directly bound by Hnf4a in wild type islets
(Figure 5C), and were markedly downregulated in Hnf4a-deficient
islets (Figure 5B). Thus, all 8 selected genes were co-occupied and
were functionally dependent on the two factors in islets. We next
examined Hnf1a binding to these sites in Hnf4a-deficient islets. We
found that in 5 of 8 genes, Hnf1a binding was maintained in islets
that lack Hnf4a (Figure 5D). In two other Hnf4a-dependent genes,
Hnf1a binding was significantly reduced in Hnf4a-deficient islets,
and was completely abrogated in one case (Figure 5D). The
difference between genes concerning Hnf1a binding in Hnf4a-
deficient islets could not be linked to differences in the affinity of
Hnf1a and Hnf4a binding sites. Thus, the synergistic activation of
common targets by Hnf1a and Hnf4a can reflect gene-specific
interdependent mechanisms at both binding and post-binding
levels.
Discussion
Epistasis reveals functional interdependence of Hnf1a
and Hnf4a in islets
We have addressed how transcription factors establish func-
tional interactions in an in vivo context. To achieve this, we studied
epistatic relationships of transcriptional phenotypes. Our approach
follows recent studies that used epistasis of transcriptomes to study
functional interactions between regulators of protein kinase A in
Dictyostelium, Mediator subunits in yeast, and most recently to
unravel yeast transcription factor networks [37–39]. Our use of
epistasis is analogous to classic studies that studied synergism or
redundancy between transcription factors by comparing cells
transfected with reporter minigenes along with single versus
multiple transcription factors[1]. In the reverse approach we
employed, we studied the transcriptome of mice with single and
double transcription factor mutations. This allowed us to study
combinatorial function in vivo, in endogenous genes of primary
mammalian cells. It also enabled a global analysis, rather than
studying specific gene targets that do not necessarily reflect a
predominant regulatory strategy. This approach complements
studies that compare the genomic location of different transcrip-
tion factors without assessing their functional interactions. Our
analysis thus confirmed previous observations that Hnf1a and
Hnf4a bind to common targets, and suggests that these two factors
function as obligate interdependent regulators in pancreatic islets.
We thus demonstrate a role for epistasis to unravel the function of
transcription factor networks in mammalian cells.
Value of weak genetic phenotypes to study regulatory
networks
Previous studies showed that homozygous Hnf1a mutant mice
exhibit full blown diabetes, in contrast to b-cell and pancreas-
Epistasis of Monogenic Diabetes Regulators
PLoS Genetics | www.plosgenetics.org 5 May 2010 | Volume 6 | Issue 5 | e1000970Figure 4. Epistasis reveals functional synergism between Hnf1a and Hnf4a. (A) Schematic representation of the genetic approach used to
test functional interactions between Hnf1a and Hnf4a in a hypothetical gene that is downregulated 50% of wild type values in both Hnf4a
pKO and
Hnf1a
+/2 islets. (B,C) Distribution of e values (see results for explanation) for control genes (B), or for all genes that were downregulated in both single
mutant mice (C). (D) Observed gene expression ratios in Hnf4a
pKO Hnf1a
+/2 islets (white circles) and expected changes in a non-epistatic model (black
circles) for each gene that was significantly downregulated in both single mutant mice.
doi:10.1371/journal.pgen.1000970.g004
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PLoS Genetics | www.plosgenetics.org 6 May 2010 | Volume 6 | Issue 5 | e1000970Figure 5. Gene-specific mechanisms for functional synergism. We tested Hnf1a binding in Hnf4a-deficient islets in 8 genes that are bound by
Hnf1a and Hnf4a in wild type islets and are downregulated in Hnf1a and Hnf4a-deficient islets. Hnf1a binding in Hnf4a-deficient islets was unaltered
in 5/8 genes examined, was partially reduced in two genes, and was abrogated in one gene. (A) Schematic representations of PCR products (black
thick lines) used for Hnf1a and Hnf4a ChIPs, and high affinity HNF1 (red vertical lines) and HNF4 (blue vertical lines) binding sequences. (B) Gene
expression in wild type and Hnf4a-deficient islets assayed by quantitative PCR. Results are normalized by expression levels of Actb mRNA, and are
shown as fold-changes relative to wild type islets. (C,D) Hnf1a and Hnf4a binding in wild type (black bars) and Hnf4a-deficient (white bars) islets.
Results are expressed as fold over Actb negative control regions. Tbp is shown as an independent negative control for both ChIP and gene expression
studies. * P,0.05.
doi:10.1371/journal.pgen.1000970.g005
Epistasis of Monogenic Diabetes Regulators
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[21,28,29,31,34,40]. In light of these differences it was somewhat
unexpected that Hnf1a and Hnf4a regulate similar islet genes. We
observed this coregulation using heterozygous Hnf1a and pancre-
as-specific Hnf4a mutations, which do not have common metabolic
disturbances that could confound the comparison. They are also
selective models: four studies have now shown that Hnf4a-deficient
islets express normal Hnf1a levels (this study, and [28–30]), and, in
contrast to Hnf1a
-/- mice, Hnf4a levels are only minimally altered
in Hnf1a
+/2 islets (this study, and [36]). Plausibly, differences in the
phenotype of Hnf1a and Hnf4a-deficient models reported so far are
due to the use of different types of genetic inactivation systems.
More generally, we believe that weak genetic perturbations can be
of great interest in studying transcription factor function, because
although they only cause mild target expression changes, they are
also less likely to disrupt downstream regulatory networks, thus
limiting the magnitude of indirect effects.
Hnf1a and Hnf4a regulate common targets
Most genes bound by Hnf4a or Hnf1a are not affected by
mutations of these two factors[11,19]. It was thus necessary to
integrate binding studies with genetic perturbation models to
understand the functional interactions between these transcrip-
tional regulators.
We observed that functional Hnf1a targets were similarly
perturbed in Hnf4a-deficient and Hnf1a-deficient islets. This
suggests that Hnf4a regulates Hnf1a function, and discards that
epistasis was simply due to the known transcriptional hierarchy in
which Hnf1a is upstream of Hnf4a. Together with the high Hnf1a/
Hnf4a co-occupancy rate reported here and previously in human
liver and islets[6], these findings suggest that epistasis between
Hnf1a and Hnf4a is at least in part due to interdependent
interactions at common direct targets. We thus propose a model
for the integrated function of Hnf1a and Hnf4a in islets whereby
Hnf1a regulates Hnf4a transcription [19,20], and furthermore
both factors act as interdependent transcriptional partners in islet-
cell targets (Figure 6). Importantly, this network model is not based
solely on binding studies, but integrates information on the
combinatorial functional interactions between these factors.
Mechanisms underlying interdependent function
Several reports have demonstrated protein-protein interactions
between Hnf1a and Hnf4a [22–24]. Such interactions can lead to
functional inhibition [23,24]. We show that although inhibitory
consequences may be prevalent in other tissues or may occur in a
small subset of genes, Hnf1a and Hnf4a largely activate genes
synergistically in pancreatic islets. Earlier gene-specific studies
have shown cooperative binding of Hnf1a and Hnf4a [2,26,27],
while Hnf4a has been shown to co-activate a gene that is only
directly bound by Hnf1a[22]. Our in vivo data showed that binding
was interdependent in a subset of targets, but also showed that in
many targets Hnf4a-deficiency does not entail decreased binding of
Hnf1a. In the latter genes Hnf4a is likely required for post-binding
functions of Hnf1a, such as the recruitment of co-regulatory
complexes required for chromatin remodelling and/or assembly of
the preinitiation complex. The mechanisms underlying functional
synergism between Hnf1a and Hnf4a therefore appear to vary
across target genes.
Implications for monogenic diabetes
Our study predicts a common islet transcriptome defect in the
pathophysiology of HNF1A and HNF4A diabetes. This is consistent
with the clinically indistinguishable diabetic phenotype of adult
HNF1A and HNF4A patients[18,41]. An exception to this notion is
that HNF4A mutations cause transient in utero and neonatal
hyperinsulinism, which later evolves to decreased insulin secretion,
whereas HNF1A mutations develop the latter phenotype without
early hyperinsulinism [30]. This may result if Hnf4a has Hnf1a-
independent functions during prenatal and neonatal developmen-
tal stages.
The interdependent function of Hnf1a and Hnf4a is also
relevant to our understanding of how haploinsufficiency of HNF1A
and HNF4A leads to b-cell dysfunction and diabetes. We
previously proposed that HNF1A or HNF4A haploinsufficiency
could lead to the disruption of a Hnf1a/Hnf4a positive cross-
regulatory network in b-cells[42]. Our current model depicted in
Figure 6 provides new elements to assess the consequences of
haploinsufficiency for the complex Hnf1a/Hnf4a network.
Synergistic Hnf1a/Hnf4a-dependent activation is expected to
result in steeper activator-response curves, and thus greater
vulnerability to decreased gene dosage. This may be more
pronounced in islet-cells, where Hnf1a and Hnf4a concentrations
are much lower than in liver and other tissues that are not
clinically afflicted in MODY[11,43]. Haploinsufficiency of either
HNF1A or HNF4A may in this manner disrupt the function of both
HNF1a and HNF4a and the common transcriptional program,
which include essential genes for the proper function of pancreatic
islets. In conclusion, these studies provide an approach to
understand the in vivo function of a regulatory network, and
increase our understanding of the mechanisms underlying
monogenic diabetes.
Materials and Methods
Mouse models and isolation of cells
Hnf4a
LoxP mice were obtained from The Jackson Laborato-
ry[44], Hnf1a
+/2 mice were provided by Frank Gonzalez
(NCI)[34]. Pdx1
Cre transgenic mice were provided by Pedro
Herrera (U. Geneva) [45]. All studies were performed according to
procedures approved by the institutional animal care and use
committee. Animals were maintained on C57B/l6 backgrounds
and genotyped as described [40]. For Hnf4a studies, Hnf4a
LoxP
littermates lacking Pdx1
Cre and Pdx1
Cre mice lacking Hnf4a
LoxP
Figure 6. Model of the Hnf1a/Hnf4a regulatory network in
pancreatic islets. In islets, Hnf1a controls Hnf4a gene transcription,
while both Hnf1a and Hnf4a activate common targets synergistically.
doi:10.1371/journal.pgen.1000970.g006
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islets from 2- to 4-month old mice were isolated as described [40].
Islets were cultured for 48 hr at 37uC, 5% CO2 in RPMI
(Invitrogen) containing 11mM glucose supplemented with 10%
FCS.
Glucose tolerance
Animals were fasted overnight and injected glucose intraperi-
toneally (2 gm/Kg). Glucose was measured from the tail vein at
0,15,30,60 and 120 min. Fasted plasma insulin was measured by
ELISA (Mercodia).
Gene expression analysis
RNA from purified islets was isolated with Trizol (Invitrogen)
and tested with an Agilent 2100 Bioanalyzer to ascertain RNA
integrity. The reduction of Hnf4a mRNA in Hnf4a
pKO mice varied
between 5–50% of wild type islets, most likely due the inherent
variability of Cre-based recombination. We thus assessed Hnf4a
mRNA by semiquantitative PCR [46] and used samples with
.80% reduction for further analysis.
For each array replicate, RNAs from 2–4 male mice were
pooled, and 50 ng was used in two cycles of cDNA synthesis for
hybridization of Affymetrix 430 2.0 arrays. For epistasis
experiments we used 8 week-old male mice. We separately
compared 16 week-old male Hnf4a
LoxP and control mice. Three
arrays (a total of 8–12 mice) were analyzed per genotype,
normalized with RMA, and analyzed with the LIMMA package
to identify downregulated genes using a multiple test adjusted P
value ,0.05. To select genes downregulated in Hnf1a
+/2 islets we
used a nominal (unadjusted) P,0.01 threshold, and validated this
set with gene-specific assays. Gene-specific expression was assessed
either with Taqman Low Density Arrays (Applied Biosystems)
using unpooled islet RNA samples from 2–3 additional mice per
genotype, or by qPCR using SybrGreen detection system as
described [11]. Gene expression datasets are available in
ArrayExpress (http://www.ebi.ac.uk) (Accession number: E-
MEXP-1729).
Chromatin immunoprecipitation (ChIP) assays
Approximately 2000 purified islets from Hnf4a
LoxP Pdx1
Cre and
littermates lacking the Pdx1
Cre transgene were used for ChIP
assays essentially as described [11,19]. For each genotype we
processed islets from two independent pools of ,10 mice
separately, we measured in duplicate the enrichment of immuno-
precipitated DNA relative to input DNA, and corrected for the
same values obtained in Actb as a negative control gene.
Computational sequence analysis
We used oPOSSUM [47], which computes a Fisher exact test to
measure over-representation of sequence elements in a gene set
relative to a background comprising all genes. We analyzed
evolutionary conserved sequences 5 Kb upstream and 5 Kb
downstream of transcription start sites of all downregulated genes
(M,20.6), and searched for conserved sequence elements as
described in [48]. The empirical recommendations to identify
binding sites oPOSSUM are a Z-score.10 and a Fisher P
value,0.01. Overrepresented motifs were tested against the
JASPAR CORE database of binding site profiles.
Epistasis and statistical analyses
Our analysis of epistasis of transcriptome phenotypes is based
on previous large-scale studies of epistasis among yeast mutants
regulating cell growth [49,50]. We selected 105 genes that were
downregulated (M,20.6) in both Hnf1a
+/2 and Hnf4a
pKO islets,
and compared gene expression changes with that of double
mutant islets. For each gene we calculated an e epistasis value that
measures the deviation of the observed mutant/wild type expression
ratio (R) in Hnf1a
+/2 Hnf4a
pKO double mutant islets from the
expected ratio based on the product of the two single mutant values
(e=R Hnf1a
+/2 Hnf4a
pKO -[ RHnf1a
+/2 xRHnf4a
pKO]). We
performed a similar analysis for a control set of genes that showed
no regulation in the two single mutant islets (M-1.1 to 1.1, p.0.2,).
We calculated statistical significance with Student’s t test,
comparing the experimental and control e value distributions, or
with a paired Student’s t test, comparing Hnf1a
+/2 Hnf4a
pKO R
values to expected [R Hnf1a
+/2 xRHnf4a
pKO] values in each gene.
Enrichment of functional annotations was examined with
GSEAv2.0 (http://www.broad.mit.edu/gsea/) using gene sets as
the permutation type and 1000 permutations, and with DAVID
(http://david.abcc.ncifcrf.gov/). Statistical significance in binding
comparisons was calculated with two-sided Fisher’s exact test, or
by testing the Hypergeometric distribution.
Supporting Information
Figure S1 Pancreatic Hnf4a-deficiency causes a mild alteration
of glucose tolerance and fasting glycemia. (A,B) Fasting blood
glucose and insulin in 8 week-old male wild type (black) versus
Hnf4a
pKO (white) littermate mice. (C) Intraperitoneal glucose
tolerance test in wild type versus Hnf4a
pKO male mice at 8 weeks of
age. All experiments were performed after an overnight fast.
Values are mean 6 SEM. * Student’s test P,0.05; n=8-15
animals per group in each experiment.
Found at: doi:10.1371/journal.pgen.1000970.s001 (0.18 MB PDF)
Figure S2 Hnf1a haploinsufficiency does not alter glucose
tolerance. (A,B) Fasting blood glucose and insulin in 52 week-old
male wild type (white) versus Hnf1a
+/- (grey) littermate mice. (C)
Intraperitoneal glucose tolerance test in wild type versus Hnf1a
+/-
male mice at 52 weeks of age. All experiments were performed
after an overnight fast. Values are mean 6 SEM. n=10-25
animals per group in each experiment. No changes in glucose
tolerance were observed at 8-48 weeks of age (not shown).
Found at: doi:10.1371/journal.pgen.1000970.s002 (0.16 MB PDF)
Figure S3 Glucose homeostasis is similar in Hnf4a
pKO and
double mutant mice. (A) Fasting blood glucose in 10 week-old
male wild type (black), Hnf1a
+/- (grey), Hnf4a
pKO (white) versus
Hnf1a
+/-;Hnf4a
pKO (grey with white dots) littermate mice. (B)
Blood glucose levels 30 minutes after intraperitoneal glucose
administration. The results show that consistent with the epistatic
interactions revealed in transcriptome comparisons, the glucose
homeostasis abnormalities do not differ in double mutant and
Hnf4a-deficient islets. Values are mean 6 SEM. Each group is
formed by 8-12 male mice. *P,0.05 relative to wild type mice.
Found at: doi:10.1371/journal.pgen.1000970.s003 (0.17 MB PDF)
Figure S4 (A) Gene-specific qPCR (Taqman) analysis of 20
genes that showed downregulation in Hnf1a
+/- islets using
Affymetrix gene chips at a nominal significance value of
P,0.01. This result confirms that this statistical threshold selects
genes that are downregulated in Hnf1a
+/- islets. (B) Assessment of
Affymetrix gene expression ratios in Hnf1a
+/- islets for Hnf1a-
bound genes that are downregulated .2-fold in Hnf1a
-/- islets
[11]. This result shows that the direct essential functions of Hnf1a
in islets are captured by expression profiling of Hnf1a
+/- islets.
Found at: doi:10.1371/journal.pgen.1000970.s004 (0.14 MB PDF)
Figure S5 Expression in Hnf4a
pKO islets for the set of genes
comprised of Hnf1a-bound genes that are downregulated .2-fold
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-/- islets. Grey dots represent average expression values of
all genes in Hnf4a
pKO versus control islets. Red dots are values for
Hnf1a-bound genes downregulated in Hnf1a
-/- islets.
Found at: doi:10.1371/journal.pgen.1000970.s005 (2.12 MB PDF)
Figure S6 Epistasis analysis validation in Hnf1a- and Hnf4a-
dependent genes. We selected a random set of genes that were
downregulated by .25% in both single Hnf1a
+/- and Hnf4a
pKO
mutant islets in Affymetrix experiments. We used gene-specific
qPCR to measure expression in the four experimental genotypes,
and compared the observed and expected expression ratios in
Hnf4a
pKO Hnf1a
+/- islets. The results represent the average of 2-3
non-pooled samples per genotype, all of which differed from the
samples used in Affymetrix chip analysis. P value was obtained by
a Paired Student’s t test.
Found at: doi:10.1371/journal.pgen.1000970.s006 (0.23 MB PDF)
Figure S7 Lack of evidence for functional redundancy between
Hnf1a and Hnf4a. We studied all genes that were downregulated
.3 fold in Hnf4a
pKO Hnf1a
+/- islets to avoid a bias against
redundancy due to the selection of genes that were downregulated
in single mutant islets. This set of genes (A) was almost invariably
also downregulated in the single mutant islets, and (B) showed in
most cases epsilon values .0, thus discarding significant
redundant functions between Hnf1a and Hnf4a in islets.
Found at: doi:10.1371/journal.pgen.1000970.s007 (0.14 MB PDF)
Figure S8 ChiP-chip analysis of Hnf4a in pancreatic islets.
Representation of genes bound at Log2 M.0.6 in a technical
replicate BCBC promoter microarray hybridization experiment
using pancreatic islets, and the corresponding binding ratios in
hepatocytes. Experiments were performed essentially as in [8].
The results show that 76% of genes bound in islets showed
concordant binding at M.0.6 in liver.
Found at: doi:10.1371/journal.pgen.1000970.s008 (0.14 MB PDF)
Table S1 Summary of gene expression findings for genes
downregulated .2 fold in Hnf4a
pKO islets.
Found at: doi:10.1371/journal.pgen.1000970.s009 (0.08 MB PDF)
Table S2 Overrepresentation of functional classes among
regulated genes in Hnf4a
pKO and Hnf1a
+/- islets.
Found at: doi:10.1371/journal.pgen.1000970.s010 (0.03 MB PDF)
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